OceansBio co.,ltd. (XKON:332190)
South Korea
· Delayed Price · Currency is KRW
4,510.00
-115.00 (-2.49%)
At close: Dec 4, 2025
OceansBio co.,ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2023 | FY 2022 |
| Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 125.65 | 16.89 |
| Revenue Growth (YoY) | 643.92% | - |
| Cost of Revenue | 36.54 | - |
| Gross Profit | 89.11 | 16.89 |
| Selling, General & Admin | 1,047 | 706.38 |
| Research & Development | 785.72 | 204.67 |
| Amortization of Goodwill & Intangibles | 6.26 | 6.09 |
| Other Operating Expenses | 22.48 | 10.42 |
| Operating Expenses | 1,951 | 1,019 |
| Operating Income | -1,862 | -1,002 |
| Interest Expense | -50.36 | -26.66 |
| Interest & Investment Income | 0.86 | 0.3 |
| Currency Exchange Gain (Loss) | -0.08 | -0.25 |
| Other Non Operating Income (Expenses) | 898.27 | 474.83 |
| Pretax Income | -1,013 | -554.1 |
| Net Income | -1,013 | -554.1 |
| Net Income to Common | -1,013 | -554.1 |
| Shares Outstanding (Basic) | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 |
| Shares Change (YoY) | -0.01% | - |
| EPS (Basic) | -686.00 | -375.00 |
| EPS (Diluted) | -686.00 | -375.00 |
| Free Cash Flow | -829.39 | -613.46 |
| Free Cash Flow Per Share | -561.38 | -415.17 |
| Gross Margin | 70.92% | 100.00% |
| Operating Margin | -1482.09% | -5934.56% |
| Profit Margin | -806.63% | -3280.74% |
| Free Cash Flow Margin | -660.10% | -3632.14% |
| EBITDA | -1,766 | -903.8 |
| D&A For EBITDA | 96.37 | 98.52 |
| EBIT | -1,862 | -1,002 |
| Advertising Expenses | 5.52 | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.